Concepedia

Sajan Khosla

SK

Statistics

Publications

15

Citations

1.3K

H-Index

14

Active since

2012

Affiliations

AstraZeneca (United Kingdom)(Current)

Queen Elizabeth Hospital Birmingham

IQVIA (United States)

University of Birmingham

Harvard University

Sajan Khosla is an author at AstraZeneca (United Kingdom) specializing in medicine, evidence-based practice, and surgery.

Publications per year

2012–2024

15

Publications

15

Weekend hospitalization and additional risk of death: An analysis of inpatient data

Nick Freemantle, Matt X. Richardson, John M. Wood et al. · Journal of the Royal Society of Medicine · 2012 · 294 citations · Full text

Social Sciences, Internal Medicine, Clinical Epidemiology +16

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Jennifer C. E. Lane, James Weaver, Kristin Kostka et al. · The Lancet Rheumatology · 2020 · 153 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Malignancy-related mortality following kidney transplantation is common

Daniela Farrugia, Sophia Mahboob, James Cheshire et al. · Kidney International · 2013 · 149 citations · Full text

Medicine, Nephrology, Surgery +14

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study

Jennifer C. E. Lane, James Weaver, Kristin Kostka et al. · medRxiv · 2020 · 133 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Benjamin Besse, Elvire Pons‐Tostivint, Keunchil Park et al. · Nature Medicine · 2024 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 15